1.Ruiz-Palacios GM. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken [Editorial commentary]. Clinical Infectious Diseases 2007; 44: 701–703.
2.Kubota K, et al. Estimating the burden of acute gastroenteritis and foodborne illness caused by Campylobacter, Salmonella, and Vibrio parahaemolyticus by using population-based telephone survey data, Miyagi Prefecture, Japan, 2005 to 2006. Journal of Food Protection 2011; 74: 1592–1598.
3.Havelaar AH, et al. Disease burden of foodborne pathogens in the Netherlands, 2009. International Journal of Food Microbiology 2012a; 156: 231–238.
4.EFSA. The community summary report on trends and sources of zoonoses and zoonotic agents in the European Union in 2007. EFSA Journal 2009; 223: 1–320.
5.Endtz HP, et al. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes. Journal of Clinical Microbiology 2000; 38: 2297–2301.
6.Ang CW, Jacobs BC, Laman JD. The Guillain-Barré syndrome: a true case of molecular mimicry. Trends in Immunology 2004; 25: 61–66.
7.Tam CC, et al. Guillain–Barré syndrome and preceding infection with Campylobacter, influenza and Epstein– Barr virus in the general practice research database. PLoS ONE 2007; 2: e344.
8.de Wit MAS, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. American Journal of Epidemiology 2001; 154: 666–674.
9.Amar CFL, et al. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993–1996). European Journal of Clinical Microbiology and Infectious Diseases 2007; 26: 311–323.
10.Madden RH, Moran L, Scates P. Frequency of occurrence of Campylobacter spp. in red meats and poultry in Northern Ireland and their subsequent subtyping using polymerase chain reaction-restriction fragment length polymorphism and the random amplified polymorphic DNA method. Journal of Applied Microbiology 1998; 84: 703–708.
11.Altekruse SF, et al. Campylobacter jejuni – an emerging foodborne pathogen. Emerging Infectious Diseases 1999; 5: 28–35.
12.Devane ML, et al. The occurrence of Campylobacter subtypes in environmental reservoirs and potential transmission routes. Journal of Applied Microbiology 2005; 98: 980–990.
14.Teunis P, et al. A reconsideration of the Campylobacter dose-response relation. Epidemiology and Infection 2005; 133: 583–592.
15.Strid MA, et al. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2 year follow-up study of 210 patients. Clinical and Diagnostic Laboratory Immunology 2001; 8: 314–319.
16.Ang CW, et al. Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients. Clinical Microbiology and Infection 2007; 13: 915–922.
17.Ang CW, et al. Seroepidemiological studies indicate frequent and repeated exposure to Campylobacter spp. during childhood. Epidemiology and Infection 2011; 139: 1361–1368.
18.Falkenhorst G, et al. Serological cross-sectional studies on Salmonella incidence in eight European countries: no correlation with incidence of reported cases. BMC Public Health 2012; 12: 523–523.
19.Versteegh FGA, et al. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiology and Infection 2005; 133: 737–748.
20.Simonsen J, et al. Estimation of incidences of infectious diseases based on antibody measurements. Statistics in Medicine 2009; 28: 1882–1895.
21.Teunis PFM, et al. Kinetics of IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiology and Infection 2002; 129: 479– 489.
22.Teunis PFM, et al. Biomarker dynamics: estimating infection rates from serological data. Statistics in Medicine 2012; 31: 2240–2248.
23.Doorduyn Y, et al. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in the Netherlands: a case-control study. Epidemiology and Infection 2010; 138: 1391–1404.
24.Scallan E. Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network: 1996–2005. Clinical Infectious Diseases 2007; 44: 718–725.
25.Black RE, et al. Experimental Campylobacter jejuni infection in humans. Journal of Infectious Diseases 1988; 157: 472–479.
26.Hellard ME, et al. Prevalence of enteric pathogens among community based asymptomatic individuals. Journal of Gastroenterology and Hepatology 2000; 15: 290–293.
27.Ekdahl K, Giesecke J. Travellers returing to Sweden as sentinels for comparative disease incidence in other European countries, Campylobacter and Giardia as examples. Eurosurveillance 2004; 9: 1–9.
28.Havelaar AH, et al. Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009. Epidemiology and Infection. Published online:13 04 2012. doi:10.1017/S0950268812000568.
29.Swart AN, et al. The protective effects of temporary immunity under imposed infection pressure. Epidemics 2012; 4: 43–47.